No. | Publication Date | Citing Article |
---|---|---|
1 | 2023 | Marzieh Mazinani, Fatemeh Rahbarizadeh. New cell sources for CAR-based immunotherapy, Biomarker Research. 2023; 11: 49. https://doi.org/10.1186/s40364-023-00482-9 |
2 | 2023 | Mohammad Reza Lahimchi, Faezeh Maroufi, Amirhosein Maali. Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor T Cells: The Intersection of Stem Cells and Immunotherapy, Cellular Reprogramming. 2023; 25: 195. https://doi.org/10.1089/cell.2023.0041 |
3 | 2024 | Claudia Juraske, Sonia M Krissmer, Evelyn S Teuber, Maria A Parigiani, Juliane Strietz, Daniela Wesch, Dieter Kabelitz, Susana Minguet, Wolfgang W Schamel. Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing, Journal of Leukocyte Biology. 2024; 115: 293. https://doi.org/10.1093/jleuko/qiad128 |